Nahdi Medical Company Nahdi Medical Company

Nahdi Medical Company

4164

Rangering i aksjer #4858
Nahdi Medical Company stands as a prominent pharmaceutical retail chain with... Nahdi Medical Company stands as a prominent pharmaceutical retail chain with operations spanning both the Kingdom of Saudi Arabia and the United Arab Emirates. Its extensive product portfolio encompasses a diverse range of pharmaceutical goods, health and wellness items, maternal and infant care essentials, beauty products, and various fast-moving consumer goods. Beyond retail, Nahdi provides a comprehensive suite of omni-health services, including polyclinics, rapid-care clinics, telemedicine platforms, laboratory facilities, and home healthcare programs. The company is also actively involved in the wholesale and retail distribution of cosmetics, medicines, specialized dietary products, healthy food options, and medical equipment. With approximately 1,151 pharmacies under its management, Nahdi Medical Company was established in 1986 and maintains its headquarters in Jeddah, Saudi Arabia. It operates as a subsidiary under the umbrella of both Alnahdi Holding Company Limited and Saudi Economic and Development Company Limited.
Aksjekurs
$23.42
Markedsverdi
$3.05B
Endring (1 dag)
-0.45%
Endring (1 år)
-27.09%
Land
SA
Handel Nahdi Medical Company (4164)

Kategori

Healthcare
Antall utestående aksjer for Nahdi Medical Company (4164)
Antall utestående aksjer per June 2026: 130.00M
Ifølge Nahdi Medical Company sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 130.00M. Ved slutten av December 2023 hadde selskapet 130.00M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Nahdi Medical Company (4164) fra 2017 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
2026 (TTM) 130.00M 0.00%
2024 130.00M 0.00%
2023 130.00M 0.00%
2022 130.00M 0.00%
2021 130.00M 0.00%
2020 130.00M 0.00%
2019 130.00M 0.00%
2018 130.00M 0.00%
2017 130.00M 0.00%
Utestående aksjer for lignende selskaper eller konkurrenter